| Brain tumour cells interconnect to a functional and resistant network M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ... Nature 528 (7580), 93-98, 2015 | 1037 | 2015 |
| Tweety-homolog 1 drives brain colonization of gliomas E Jung, M Osswald, J Blaes, B Wiestler, F Sahm, T Schmenger, G Solecki, ... Journal of Neuroscience 37 (29), 6837-6850, 2017 | 147 | 2017 |
| Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei T Schirmeister, J Schmitz, S Jung, T Schmenger, RL Krauth-Siegel, ... Bioorganic & Medicinal Chemistry Letters 27 (1), 45-50, 2017 | 47 | 2017 |
| Inhibition of CD95/CD95L (FAS/FASLG) signaling with APG101 prevents invasion and enhances radiation therapy for glioblastoma J Blaes, CM Thomé, PN Pfenning, P Rübmann, F Sahm, A Wick, T Bunse, ... Molecular cancer research 16 (5), 767-776, 2018 | 35 | 2018 |
| A glutaredoxin in the mitochondrial intermembrane space has stage-specific functions in the thermo-tolerance and proliferation of African trypanosomes S Ebersoll, B Musunda, T Schmenger, N Dirdjaja, M Bonilla, B Manta, ... Redox Biology 15, 532-547, 2018 | 20 | 2018 |
| Never-homozygous genetic variants in healthy populations are potential recessive disease candidates T Schmenger, GD Diwan, G Singh, G Apic, RB Russell NPJ Genomic Medicine 7 (1), 54, 2022 | 7 | 2022 |
| Reduced protein stability of 11 pathogenic missense STXBP1/MUNC18-1 variants and improved disease prediction T André, AA van Berkel, G Singh, ET Abualrous, GD Diwan, T Schmenger, ... Biological psychiatry, 2024 | 1 | 2024 |
| Discriminating activating, deactivating and resistance variants in protein kinases G Singh, T Schmenger, JC Gonzalez-Sanchez, A Kutkina, N Bremec, ... | | 2024 |
| PROTEORIZER: A holistic approach to untangle functional consequences of variants of unknown significance. T Schmenger, G Diwan, RB Russell bioRxiv, 2024.07. 16.603688, 2024 | | 2024 |
| Exploration of Natural Variants in Human Health and Disease T Schmenger | | 2023 |
